Scientists at Mizzou have identified two small molecules, agmatine and thiamine, that could both reveal and fight glaucoma.

Glaucoma is the term for a group of eye conditions that damage the optic nerve at the back of the eye. Without treatment, it can lead to vision loss and blindness. Glaucoma is not a life threatening ...

Oluwatosin U. Smith, MD, reflects on early experiences caring for pediatric patients with complex glaucoma and how evolving ...

AND JESS, YOU SAY THIS COULD BE A GAME CHANGER. YOU KNOW, IT REALLY CAN. ABOUT 3 MILLION AMERICANS HAVE GLAUCOMA AND THIS NEW TREATMENT IS BASICALLY AN IMPLANTABLE DRUG FOR THE EYE. AND DOCTORS SAY IT ...

From MIGS integration to remote monitoring and next-generation therapeutics, glaucoma specialists explore how new approaches ...

Glaucoma is a devastating eye disease that currently affects more than 3 million Americans. By the year 2050, data shows the number of cases is projected to surge to more than 6 million cases. This is ...

The findings could enable earlier detection and treatment for people affected by the serious eye condition. A research team ...

Valley Health System is opening a glaucoma center at its ophthalmology practice in Ridgewood. Located at 1200 East Ridgewood Ave., the new group specializes in traditional and minimally invasive ...

Please provide your email address to receive an email when new articles are posted on . More than half of all patients treated with glaucoma medications have ocular surface disease, which ...

The Cleveland Clinic explains that glaucoma, also referred to as the “silent thief of sight,” is a group of eye diseases that gradually damage the optic nerve, typically due to increased pressure ...

International health policy and German development cooperation focus primarily on preventive measures. This is evident, for ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up Glaucoma is a complex group of eye diseases that lead to ...